ArticleLasers in medical science2025
Evaluation of antimicrobial photodynamic therapy with erythrosine and blue light emitting diode for inactivation of Aggregatibacter actinomycetemcomitans.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of antimicrobial photodynamic therapy with Butyl toluidine blue O for inactivation of Aggregatibacter actinomycetemcomitans biofilm.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This study aims to analyze the effect of antimicrobial photodynamic therapy on Aggregatibacter actinomycetemcomitans using erythrosine as a photosensitizer and a blue light emitting-diode as a light source. Inoculum samples of A. actinomycetemcomitans with PBS were used in each of the groups, being the control group (C); light group (L) corresponding to light emitting-diode irradiation for 300 s; photosensitizing group (0) without irradiation; and the aPDT groups with different irradiation times (aPDT20) with 20s of irradiation; (aPDT40) with 40s of irradiation; (aPDT60) with 60s of irradiation; (aPDT180) with 180s; and (aPDT300) with 300s. Samples were used to determine colony forming units (CFU). Aliquots of 10 µL were plated through six serial dilutions on brain-heart infusion agar in Petri dishes. The plates were incubated at 37 °C for a period of up to 24-48 h under microaerophilic conditions to evaluate the total bacteria recovered. After this period, CFUs were counted, and the data was subjected to one-way analysis of variance. When aPDT was performed for 180 and 300 s, the mean log10 (CFU/ml) was equal to 0. In the aPDT60 group, a significant yet incomplete microbial reduction was observed. SEM images confirmed that membrane integrity was maintained, indicating that aPDT induced cellular alterations without causing membrane disruption. Antimicrobial photodynamic therapy employing erythrosine as a photosensitizer and blue light emitting-diode light-curing unit for composite resin polymerization used in dental practices demonstrated significant antimicrobial efficacy against A. actinomycetemcomitans, a principal pathogen in periodontitis, under the evaluated experimental conditions.
Indexed as
Identifiers
40227489What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.